HeartSciences Inc. (HSCSW) cash flow statement

HSCSWNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCS

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 3/30

$0.07−0.03 (-30.62%)

Close on Oct 30, 2026Market cap $15.89MP/E –Yield 0.00%

HeartSciences Inc. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q1 2027 2026-07-31	TTM FY 2026 2026-04-30	TTM Q3 2026 2026-01-31	TTM Q2 2026 2025-10-31	TTM Q1 2026 2025-07-31	TTM FY 2025 2025-04-30	TTM Q3 2025 2025-01-31	TTM Q2 2025 2024-10-31	TTM Q1 2025 2024-07-31	TTM FY 2024 2024-04-30	TTM Q3 2024 2024-01-31	TTM Q2 2024 2023-10-31	TTM Q1 2024 2023-07-31	TTM FY 2023 2023-04-30	TTM Q3 2023 2023-01-31	TTM Q2 2023 2022-10-31	TTM Q1 2023 2022-07-31	TTM FY 2022 2022-04-30
Stock-Based Compensation	1.88	1.31	1.08	0.76	0.37	0.25	0.23	0.27	0.33	0.41	0.43	0.33	0.23	0.25	0.10	0.21	0.21	0.07
Change in Accounts Receivable	0	0.00	0	–	–	0.00	–	–	–	–	–	–	–	0.00	–	–	–	–
Change in Inventory	-0.01	-0.01	-0.01	0.00	-0.01	-0.02	0.02	0.02	–	0.05	–	–	–	0.00	0.00	0.02	0.04	0.08
Change in Accounts Payable	0.74	0.00	0.01	0.04	-0.11	-0.13	-0.01	-0.81	-0.06	-0.18	-0.61	0.31	0.02	0.04	0.72	0.45	0.28	0.36
Operating Cash Flow	-6.79	-7.43	-7.34	-7.50	-7.35	-7.41	-7.40	-7.88	-6.68	-6.07	-6.36	-5.27	-5.37	-5.77	-5.10	-5.05	-4.74	-3.64
Capital Expenditures	–	0.00	–	–	–	0.00	–	–	–	-0.06	-0.02	-0.02	-0.02	-0.02	-0.01	-0.01	–	0.00
Investing Cash Flow	-0.32	-0.04	-0.05	-0.04	-0.03	-0.03	-0.09	-0.13	-0.12	-0.13	-0.06	-0.02	-0.02	-0.02	-0.01	-0.01	–	0.00
Stock Issued	–	0.17	–	–	–	1.15	–	–	–	–	–	–	–	5.19	–	–	–	–
Financing Cash Flow	4.35	8.03	8.19	5.44	5.83	2.73	3.01	12	11	10	12	2.32	1.69	6.53	5.72	7.76	–	3.84
Net Change in Cash	-2.76	0.56	0.80	-2.10	-1.55	-4.71	-4.48	3.95	3.76	4.15	5.15	-2.98	-3.70	0.74	0.60	2.71	4.27	0.19
Free Cash Flow	–	-7.43	–	–	–	-7.42	–	–	–	-6.13	-6.38	-5.29	-5.38	-5.79	-5.11	-5.06	–	-3.65

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 60.9%
Operating margin: -209733.1%
Net margin: -227024.2%
Return on equity, FY2026: -4239.9%

Financial strength

Current ratio: 0.14
Debt to equity: 0.00
Debt to assets: 0.0%
Cash to current liabilities: 0.5%

Valuation

P/E ratio: –
Price to sales: 3515.95
Price to book: –
Dividend yield: 0.00%